VICR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. VICR just sold off hard (-8.08% regular session) and momentum has turned down (MACD negative and worsening). While the bigger-picture trend still looks constructive (bullish moving-average stack) and fundamentals/analyst view are improving, the near-term setup favors more chop or further downside before a cleaner entry. I would wait for stabilization/reclaim of the ~160.5 pivot or a clear bounce off ~149.6 support; buying immediately is not the best risk/reward today.
Price/Trend: Sharp drop from 171.53 to 156.5 puts the stock below the 160.547 pivot, indicating near-term control shifted to sellers. Momentum: MACD histogram -0.15 and negatively expanding = bearish momentum increasing. RSI: RSI(6) ~49.8 = neutral, not oversold yet (so there’s room to fall before forced mean reversion). Moving Averages: SMA_5 > SMA_20 > SMA_200 remains bullish, suggesting the larger trend may still be up, but the latest selloff is a near-term trend break/risk-off impulse. Levels: Resistance at 160.55 (pivot) then 171.52 (R1). Support at 149.58 (S1) then 142.80 (S2). A loss of ~149.6 would materially worsen the short-term picture.
Intellectia Proprietary Trading Signals
Strong operating momentum (latest quarter shows accelerating profitability and margin improvement).
Analyst stance is constructive: Roth Capital keeps a Buy and raised the price target to $175 (from $115), citing faster fab fill and potential for a second fab plus higher margin potential (gross margin objective possibly 65% to 70%).
Call-heavy option volume suggests traders are positioning for a bounce.
Near-term technical damage: large single-day selloff and MACD turning down and worsening.
No news catalysts in the past week to explain/support an immediate reversal; bounce may rely purely on technical mean reversion.
Key downside risk if price breaks below ~149.6 support (next support ~142.8).
Latest reported quarter: 2025/Q3. Revenue: $110.423M, +18.52% YoY (solid top-line acceleration). Net income: $28.292M, +144.91% YoY (strong operating leverage). EPS: $0.63, +142.31% YoY. Gross margin: 57.52%, +17.15% YoY (meaningful margin expansion trend). Overall: Fundamentals are improving sharply, supporting a bullish longer-term view, but this strength is not currently being rewarded in today’s price action.
Recent trend: Roth Capital initiated coverage (Buy, $115 PT on 2025-12-16), then materially raised its PT to $175 on 2026-01-22 while reiterating Buy—an upward revision trend. Wall Street pros: faster capacity fill, potential second fab timing, licensing/royalty ramp, and margin upside. Wall Street cons (implied from setup): execution/capacity scaling risk and the market’s current reluctance to pay up in the near term (reflected by the sharp pullback). Ownership/Influencers: Hedge funds neutral; insiders neutral; no recent congress trading data available and no politician activity provided.
